Quest Partners LLC Travere Therapeutics, Inc. Transaction History
Quest Partners LLC
- $575 Billion
- Q1 2024
A detailed history of Quest Partners LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 4,209 shares of TVTX stock, worth $41,164. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,209
Previous 2,325
81.03%
Holding current value
$41,164
Previous $20.9 Million
55.25%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TVTX
# of Institutions
183Shares Held
91.5MCall Options Held
66.9KPut Options Held
265K-
Black Rock Inc. New York, NY7.8MShares$76.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$73.4 Million0.79% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$72.1 Million1.88% of portfolio
-
State Street Corp Boston, MA6.61MShares$64.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.27MShares$61.3 Million0.0% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $628M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...